208 filings
Page 9 of 11
EFFECT
tcrorx xtc
20 Dec 16
Notice of effectiveness
12:00am
S-3/A
8to26 3sy6b5w
19 Dec 16
Shelf registration (amended)
12:00am
CORRESP
e2u0a 6q6
19 Dec 16
Correspondence with SEC
12:00am
UPLOAD
pslqq
19 Dec 16
Letter from SEC
12:00am
8-K
9224vss
7 Dec 16
Voyager Therapeutics Announces Positive Interim Results from Phase 1b Trial of VY-AADC01 for Advanced Parkinson’s Disease
12:00am
S-3
s3u51g1cmmpenghksrz
1 Dec 16
Shelf registration
12:00am
8-K
jrbfc9b0z03zqtmw4n0w
10 Nov 16
Voyager Therapeutics Provides Third Quarter 2016 Investor Update
12:00am
8-K
u28j6xhs qcisuzchqh
18 Oct 16
Departure of Directors or Certain Officers
12:00am
8-K
mw5cqh
11 Aug 16
Voyager Therapeutics Provides Second Quarter 2016 Investor Update
12:00am
8-K
0nyytr6jki h93wtk
16 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
e68t9y
12 May 16
Voyager Therapeutics Provides First Quarter 2016 Investor Update
12:00am
DEF 14A
yzf6b42s30qcxik2hvj
22 Apr 16
Definitive proxy
12:00am
S-8
qbqsx5 8s
17 Mar 16
Registration of securities for employees
12:00am
10-K
uyu5lqocbn
17 Mar 16
Annual report
12:00am
8-K
cy9a9ny
17 Mar 16
Voyager Therapeutics Provides Fourth Quarter and Full Year 2015 Investor Update
12:00am
8-K
mwl4hsz19 u2ttko
17 Dec 15
Voyager Therapeutics Reports Third Quarter 2015 Financial Results
12:00am
10-Q
m8xjd3xhe5ihq
17 Dec 15
Quarterly report
12:00am